Medicines Australia appoints new chairman
The Board of Medicines Australia today announced the appointment of Mr Mark Masterson as its new chairman.
Mr Masterson was formerly chief executive at I-MED Network, Australia’s largest private diagnostic imaging network. This follows a 20 year career in international and Australian roles in the medicines industry as vice president, Asia Pacific Africa at Abbott and General Manager ANZ at Abbott Laboratories.
Mr Masterson said: “I am very excited to be joining the Medicines Australia Board as Chairman at a time of great opportunity and challenge for the medicines industry.
“This is a genuinely exciting time for the industry in Australia and I am looking forward to working with the board and with our member companies to ensure we can capitalise on some of those opportunities.”
“While the industry is facing many challenges here and internationally, fundamentally this is an industry that deserves greater recognition for the value it brings to society.
“I look forward to representing the industry in Australia as a way to promote the value that it contributes.
Medicines Australia chief executive Dr Brendan Shaw said Mr Masterson’s appointment was extremely positive for the medicines industry.
“Mark’s vast and varied experience in numerous senior roles globally in Australia will be enormously valuable to the board and membership of Medicines Australia,” Dr Shaw said.
“He will be a passionate advocate for the interests of our member companies.”
Mr Masterson succeeds Will Delaat, who retired as independent chairman of Medicines Australia after 14 years on the board and six as chairman.
Media Communications Manager
Phone: 0419 220 293